NASDAQ
Candel Therapeutics, Inc. (CADL) has a free cash flow growth of -70.47% as of Friday, May 29, 2026. This represents a 282.04% decrease compared to its 12-month average of -18.44%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.